26 published brand profiles in this category. Cite the individual brand profile for brand-specific facts.
Adimmune Corporation - Adimmune Corporation is a vaccines brand headquartered in Taichung, Taiwan, founded in 1966.
Altimmune - Altimmune is a vaccines brand headquartered in Gaithersburg, MD, founded in 1997.
Bavarian Nordic - Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France.
Bavarian Nordic A/S - Continued strong momentum in Travel Health, delivering 30% growth combined with another year supporting the global public health response against mpox.
Celldex Therapeutics - Our lead program barzolvolimab is a humanized monoclonal antibody inhibitor of KIT, a key receptor tyrosine kinase required for the function and survival of mast cells, which play a central role in the onset and progression of many severe inflammatory, allergic and autoimmune diseases. By targeting a core pathological driver of these diseases, we have designed barzolvolimab with the potential to be a best-in-class treatment option and improve the lives of patients. Driven by our deep and longsta
Chugai Pharmaceutical - Chugai Pharmaceutical is a vaccines company headquartered in Tokyo, Japan, founded in 1925.
CureVac AG - CureVac AG is a vaccines company headquartered in Tübingen, Germany, founded in 2000.
Dynavax Technologies - text/html; charset=utf-8"> <title>About | Core Values | Management | Board of Director | Dynavax Technologies</title> <meta content=
Emergent BioSolutions - Emergent BioSolutions is a vaccines company headquartered in Gaithersburg, MD, founded in 1998.
Genocea Biosciences - Genocea Biosciences is a vaccines brand headquartered in Cambridge, MA, founded in 2006.
GeoVax - Invert colors Monochrome Dark contrast Light contrast Low saturation High saturation Highlight links Highlight headings Screen reader Read mode Content scaling 100% Font size 100% Line height 100% Letter spacing 100% (678) 384-7220 info@geovax.com Serving Humanity Through Innovations in Immunology GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer using novel proprietary platforms.
GeoVax Labs - Invert colors Monochrome Dark contrast Light contrast Low saturation High saturation Highlight links Highlight headings Screen reader Read mode Content scaling 100% Font size 100% Line height 100% Letter spacing 100% (678) 384-7220 info@geovax.com Serving Humanity Through Innovations in Immunology GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer using novel proprietary platforms.
Gritstone bio - After emerging from Chapter 11 bankruptcy, hiring a new management team and a dedicated new team of scientists, Gritstone bio is changing its name to Nexoplex bio. This change is reflective of new energy and focus on the development of our portfolio of bispecific antibodies. Watch for more exciting updates as our team progresses our portfolio of bispecifics to provide treatments for unmet needs in oncology.
HDT Bio - Leveraging the body's immune system with a transformative therapeutic platform in cancer and infectious diseasesHDT Bio is a clinical stage private company developing advanced products to treat and prevent cancer and infectious diseases. Utilizing our proprietary LION™ technology, our products feature superior safety, potency, durability, and manufacturing advantages. Leveraging the body's immune system with a transformative therapeutic platform in cancer and infectious diseasesHDT Bio is a clin
HOOKIPA Pharma - HOOKIPA Pharma is a vaccines brand headquartered in Vienna, Austria, founded in 2011.
Inovio Pharmaceuticals - INOVIO is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to treat or prevent disease. We have a deep clinical pipeline with multiple potential near- and mid-term catalysts, including a Biologics License Application (BLA) currently under FDA review for lead candidate INO-3107 for the treatment of Recurrent Respiratory Papillomatosis (RRP), a rare HPV-related disease of the respiratory tract, as well as other late stage HPV-related and oncology candi
Medicago - Medicago is a vaccines company headquartered in Quebec City, Canada, founded in 1999.
Mitsubishi Tanabe Pharma - Mitsubishi Tanabe Pharma is a vaccines company headquartered in Osaka, Japan, founded in 1678.
Novavax - Novavax is a biotech company with a proven technology, focused on developing our R&D assets and establishing partnerships to help protect health.
Providence Therapeutics - Good communication and teamwork are key to our success, especially in the fast-changing world of biotechnology. Our team's ability to think ahead and make smart decisions is enhanced by their experience, including involvement in therapeutic initiatives and guiding companies through the process of becoming publicly traded. This experience provides us with invaluable insights and strategic planning capabilities.
Vaccine Technologies Inc - Vaccine Technologies Inc is a vaccines company headquartered in Cambridge, MA, founded in 2018.
Valneva - We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs.
Variation Biotechnologies - Variation Biotechnologies is a vaccines company headquartered in Waltham, MA, founded in 2012.
Vaxart - Prior to Vaxart, Mr. Lo was Chief Executive Officer and a member of the board of directors of Valitor, a private biotech company, from 2022 to 2024. From 2019 to 2022, he was the President, Chief Executive Officer, and member of the board of directors of Zosano Pharma.
Vaxxinity - Best-in-class, long-lasting, well tolerated, cost-effective, and effective against emerging variants with no frozen cold chain, mRNA, or spike protein.
VBI Vaccines - When properly stimulated, the human immune system is incredibly powerful and has profound potential. Because of their structural similarity to viruses presented in nature, virus-like particles (VLPs) are ideal for stimulating potent immune responses. Most of the emerging and re-emerging viruses that pose significant health threats are enveloped viruses, making them a prime target for VBI’s proprietary enveloped virus-like particle (eVLP) platform technology.